Omar Al Dhaybi, M.D., MSc, FASN
Member
Director, American Heart Association Comprehensive Hypertension Center, Mount Sinai Fuster Heart Hospital; Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai.
Scientific Advisory Board
Formed 14 September 2026. Members advise on hypertension, nephrology, cardiology and the design of cardiovascular trials as the Phase 2b study proceeds.
Affiliations as published in the company announcement. This page is the public SAB record; it is separate from Leadership and from internal scientific and regulatory consultants.
Member
Director, American Heart Association Comprehensive Hypertension Center, Mount Sinai Fuster Heart Hospital; Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai.
Member
Adolph Hutter Professor of Medicine, Harvard Medical School; Massachusetts General Hospital Cardiology Division; Chief Scientific Officer and C. Michael Gibson Chair, Baim Institute for Clinical Research.
Member; Chair of the Steering Committee, Phase 2b trial
Preventive Cardiology & Rehabilitation, Cleveland Clinic; Medical Director, C5Research; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine.
Member
Professor of Therapeutics, University of Cambridge; Director, Cambridge Clinical Trials Unit; President, British and Irish Hypertension Society.
Member
Director, Division of Hypertension, Massachusetts General Hospital Heart Center; Associate Professor of Medicine, Harvard Medical School.